// App-Quantinova.ai

ABS221 : EXPLORING THE PRESENCE AND IMPACTS OF GUM BLEEDING IN VON WILLEBRANDS DISEASE – WHAT LIES BENEATH THE DATA?

Researchers

Presenter

  • D. Noone

Principal Investigators

  • F. Brennan

  • M. Degenaar

  • L. Nanayakkara

  • M. Lavin

  • B. Daly

  • A. Dougall

Medical Centers

  • European Haemophilia Consortium, Burssels, Belgium

  • QMUL School of Medicine and Dentistry

  • Barts Health NHS Trust, London, United Kingdom

  • Irish Centre for Vascular Biology, RCSI

  • Trinity College

  • Dublin Dental University Hospital

  • National Coagulation Centre, St James's Hospital, Dublin, Ireland

Locations

  • Belgium

  • United Kingdom

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved